Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men

Lancet

Volumn 351, Issue 9096, 1998, Pages 88-92

  Ridker, Paul M ^a   Hennekens, Charles H ^a,b,c   Roitman Johnson, Beatrice ^d   Stampfer, Meir J ^a,c   Allen, Jean ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d R and D Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; HEART INFARCTION; HUMAN; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK; VASCULAR ENDOTHELIUM;

EID: 0032501738     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09032-6     Document Type: Article

References (33)

1. 1 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 363: 801-09.
2. 2 Springer TA. Adhesion molecules of the immune system. Nature 10090; 346: 425-34.
3. 3 Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 25: 788-91.
4. 4 Bevilacqua MP, Nelson RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 1994; 45: 361-78.
5. 5 Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-36.
6. 6 Pober JS, Gimbrone MA Jr, Lapiette LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumour necrosis factor, and immune interferon. J Immunol 1986; 137: 1893-96.
7. 7 Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992; 140: 665-73.
8. 8 Printseva OY, Peclo MM, Gown AM. Various cell types in human atherosclerotic lesions express ICAM-1: further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 1992; 140: 889-96.
9. 9 van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic \esions. Am J Pathol 1992; 141: 1427-33.
10. 10 Davies MJ, Gordon JL, Gearing AJH, et al. The expression of the adhesion molecules ICAM-1, VACM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993; 171: 223-29.
11. 11 O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996; 93: 672-82.
12. 12 Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994; 24: 1591-601.
13. 13 Peter K, Naworth P, Conradt C, et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997; 17: 505-12.
14. 14 Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994; 74: 151-54.
15. 15 Hackman A, Abe Y, Insull W, et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996; 93: 1334-38.
16. 16 Blann AD, Steele C, McCollum CN. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb 1997; 85: 433-38.
17. 17 Ridker PM, Cushman M, Stampfer MJ, Tracey RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-79.
18. 18 Steering Committee of the Physicians' Health Study Research Group. Final report of the aspirin component of the ongoing Physicians; Health Study. N Engl J Med 1989; 321: 129-35.
19. 19 Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993; 270: 2195-99.
20. 20 Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-68.
21. 21 Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently health men. Circulation 1994; 90: 2236-40.
22. 22 Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risks of future venous thromboembolism. Circulation 1997; 95: 1777-82.
23. 23 Dustin ML, Rothlein R, Bhan AR, Dinarello CA, Springer TA. Induction by IL-1 and interferon, tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-54.
24. 24 Zouki C, Beauchamp M, Baron C, Filep JG. Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest 1997; 100: 522-29.
25. 25 Languino LR, Plescia J, Duperray A, et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1 dependent pathway. Cell 1993; 73: 1423-34.
26. 26 Duperray A, Languino LR, Plescia, et al. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 1997; 272: 435-41.
27. 27 Gardiner EE, D'Souza SE. A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J Biol Chem 1997; 272: 15474-80.
28. 28 Leewenberg JFM, Smeets EF, Neefjes JJ, et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992; 77: 543-49.
29. 29 Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 584-89.
30. 30 Ma X, Lefer DJ, Lefer AM, Rothlin R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992; 86: 937-46.
31. 31 Yasukawa H, Imaizumi T, Matsuoka H, Nakashima A, Moritmatsu M. Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. Circulation 1997; 95: 1515-22.
32. 32 Plow EF, D'Souza SE. A role for intercellular adhesion molecule-1 in restenosis. Circulation 1997; 95: 1355-56.
33. 33 Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-50.